RxDoctor Payments Data

Courtney Bell, MD

Adult Reconstructive Orthopaedic Surgery · Naples, FLNPI 1073936282

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $86,978 of the $138,222 with a category attached, or 62.9%. Smith+Nephew accounts for 82.0% of it on its own, with 17 other manufacturers making up the rest.

$138,222in general payments, 2019–2025

Across 247 payments — averaging $559.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$113K
  • Depuy Synthes Products, Inc.$12K
  • Medical Device Business Services, Inc.$7K
  • Stryker$5K
  • Encore Medical, LP$430
  • Hikma Pharmaceuticals USA$423
  • plus $724 from 12 others

What the payments were for

  • Consulting fees$86,97863%
  • Speaking & faculty fees$14,20510%
  • Travel & lodging$27,69720%
  • Food & beverage$8,3856%
  • Education$9561%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$138,222 in reported general payments places this provider in the 85th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.

See all adult reconstructive orthopaedic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$208,181
Medicare patients
390
Services billed
1,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib26$245
Methylprednisolone24$113
Amoxicillin62$98
Tramadol Hcl27$86
Meloxicam11$22

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →